|
[1] SIEGEL RL,MILLER KD,JEMAL A. Cancer statistics,2018[J]. CA Cancer J Clin,2018,68(1):7-30.
|
|
[2] ZHENG RS,SUN KX,ZHANG SW,et al. Prevalence of malignant tumors in China,2015[J]. Chin J Oncol,2019,41(1):19-28.(in Chinese)郑荣寿，孙可欣，张思维，等．2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019,41(1):19-28.
|
|
[3] SIEGEL RL,MILLER KD,JEMAL A. Cancer statistics,2020[J]. CA Cancer J Clin,2020,70(1):7-30.
|
|
[4] ZENG H,CHEN W,ZHENG R,et al. Changing cancer survival in China during 2003-15:A pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health,2018,6(5):e555-e567.
|
|
[5] BRODY JR,WITKIEWICZ AK,YEO CJ. The past,present,and future of biomarkers:A need for molecular beacons for the clinical management of pancreatic cancer[J]. Adv Surg,2011,45:301-321.
|
|
[6] PORUK KE,GAY DZ,BROWN K,et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma:Diagnostic and prognostic updates[J]. Curr Mol Med,2013,13(3):340-351.
|
|
[7] ZHAN HY,HUANG CW,LIN LQ,et al. The clinical value of tumor marker CA19-9 and CA242 in pancreatic cancer[J].Clin J Diffic Complcas,2006,5(3):186-188.(in Chinese)詹海勇，黄聪武，林銮群，等．血清糖链抗原19-9和糖链抗原242诊断胰腺癌的临床价值[J]．疑难病杂志，2006,5(3):186-188.
|
|
[8] LUO G,LIU C,GUO M,et al. Potential biomarkers in lewis negative patients with pancreatic cancer[J]. Ann Surg,2017,265(4):800-805.
|
|
[9] TONG X,XIAO D,YAO F,et al. Astragalus membranaceus as a cause of increased CA19-9 and liver and kidney cysts:A case report[J]. J Clin Pharm Ther,2014,39(5):561-563.
|
|
[10] LI X,GUO X,LI H,et al. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer[J]. Tumour Biol,2014,35(6):5281-5286.
|
|
[11] KAUR S,BAINE MJ,JAIN M,et al. Early diagnosis of pancreatic cancer:Challenges and new developments[J]. Biomark Med,2012,6(5):597-612.
|
|
[12] GU YL,LAN C,PEI H,et al. Applicative value of serum CA19-9,CEA,CA125 and CA242 in diagnosis and prognosis for patients with pancreatic cancer treated by concurrent chemoradiotherapy[J]. Asian Pac J Cancer Prev,2015,16(15):6569-6573.
|
|
[13] DIAZ LA Jr,BARDELLI A. Liquid biopsies:Genotyping circulating tumor DNA[J]. J Clin Oncol,2014,32(6):579-586.
|
|
[14] EARL J,GARCIA-NIETO S,MARTINEZ-AVILA JC,et al.Circulating tumor cells(Ctc)and kras mutant circulating free Dna(cfdna)detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer[J]. BMC Cancer,2015,15:797.
|
|
[15] LIU H,SUN B,WANG S,et al. Circulating tumor cells as a biomarker in pancreatic ductal adenocarcinoma[J]. Cell Physiol Biochem,2017,42(1):373-382.
|
|
[16] SAUSEN M,PHALLEN J,ADLEFF V,et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients[J]. Nat Commun,2015,6:7686.
|
|
[17] COHEN JD,JAVED AA,THOBURN C,et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers[J]. Proc Natl Acad Sci U S A,2017,114(38):10202-10207.
|
|
[18] GANDOLFI L,TORRESAN F,SOLMI L,et al. The role of ultrasound in biliary and pancreatic diseases[J]. Eur J Ultrasound,2003,16(3):141-159.
|
|
[19] AHN SS,KIM MJ,CHOI JY,et al. Indicative findings of pancreatic cancer in prediagnostic CT[J]. Eur Radiol,2009,19(10):2448-2455.
|
|
[20] TREADWELL JR,ZAFAR HM,MITCHELL MD,et al. Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma:A meta-analysis[J]. Pancreas,2016,45(6):789-795.
|
|
[21] FRANCIS IR. Pancreatic adenocarcinoma:Diagnosis and staging using multidetector-row computed tomography(MDCT)and magnetic resonance imaging(MRI)[J]. Cancer Imaging,2007,7(Special issue A):s160-s165.
|
|
[22] DAS KK,EARLY D. Pancreatic cancer screening[J]. Curr Treat Options Gastroenterol,2017,15(4):562-575.
|
|
[23] FATTAHI R,BALCI NC,PERMAN WH,et al. Pancreatic diffusion-weighted imaging(DWI):Comparison between massforming focal pancreatitis(FP),pancreatic cancer(PC),and normal pancreas[J]. J Magn Reson Imaging,2009,29(2):350-356.
|
|
[24] HIRSCH FW,SATTLER B,SORGE I,et al. PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner[J]. Pediatr Radiol,2013,43(7):860-875.
|
|
[25] OZAWA Y,NUMATA K,TANAKA K,et al. Contrast-enhanced sonography of small pancreatic mass lesions[J]. J Ultrasound Med,2002,21(9):983-991.
|
|
[26] HIROOKA Y,GOTO H,ITO A,et al. Recent advances in US diagnosis of pancreatic cancer[J]. Hepatogastroenterology,2001,48(40):916-922.
|
|
[27] AGARWAL B,ABU-HAMDA E,MOLKE KL,et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer[J]. Am J Gastroenterol,2004,99(5):844-850.
|
|
[28] BUCHS NC,FROSSARD JL,ROSSET A,et al. Vascular invasion in pancreatic cancer:Evaluation of endoscopic ultrasonography, computed tomography, ultrasonography, and angiography[J]. Swiss Med Wkly,2007,137(19-20):286-291.
|
|
[29] FUSAROLI P,SPADA A,MANCINO MG,et al. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses[J]. Clin Gastroenterol Hepatol,2010,8(7):629-634.
|
|
[30] OHNO E,ITOH A,KAWASHIMA H,et al. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes:Focus on malignant transformation of intraductal papillary mucinous neoplasm itself[J]. Pancreas,2012,41(6):855-862.
|
|
[31] IIBOSHI T,HANADA K,FUKUDA T,et al. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer:Establishing a new method for the early detection of pancreatic carcinoma in situ[J]. Pancreas,2012,41(4):523-529.
|
|
[32] ZHANG H,WU X,ZHU F,et al. Systematic review and meta-analysis of minimally invasive versus open approach for pancreaticoduodenectomy[J]. Surg Endosc,2016,30(12):5173-5184.
|
|
[33] CAO F,LI J,LI A,et al. Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer:A systemic review and metaanalysis[J]. BMC Surg,2017,17(1):67.
|
|
[34] GAROFALO MC,NICHOLS EM,REGINE WF. Optimal adjuvant therapy for resected pancreatic cancer:Chemotherapy or chemoradiotherapy?[J]. Gastrointest Cancer Res,2007,1(5):182-187.
|
|
[35] SIDDIQUI AA,MEHENDIRATTA V,LOREN D,et al. Self-expanding metal stents(SEMS)for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer:Outcomes in 241 patients[J]. Dig Dis Sci,2013,58(6):1744-1750.
|
|
[36] MEYERS MO,MESZOELY IM,HOFFMAN JP,et al. Is reporting of recurrence data important in pancreatic cancer?[J].Ann Surg Oncol,2004,11(3):304-309.
|
|
[37] ARNAOUTAKIS GJ,RANGACHARI D,LAHERU DA,et al.Pulmonary resection for isolated pancreatic adenocarcinoma metastasis:An analysis of outcomes and survival[J]. J Gastrointest Surg,2011,15(9):1611-1617.
|
DownLoad: